GLP-1 receptor agonist
Compounded Semaglutide
A widely studied GLP-1 medication, prescribed by independently licensed providers and prepared by licensed compounding pharmacies.
$149/mo — flat at every dose
Takes ~5 min · 100% online · Free to start
Compounded semaglutide is a GLP-1 receptor agonist prepared by state-licensed 503A compounding pharmacies under prescription. A typical protocol starts at 0.25 mg weekly and titrates over 4 to 8 weeks under the supervision of a licensed provider. Compounded semaglutide is not FDA-approved as a finished product, and individual results vary.
Reviewed by the Toned editorial team · Last reviewed July 7, 2026
Education
What it is
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a naturally occurring hormone your body releases after eating. Semaglutide is also the active ingredient in the brand-name medications Ozempic (approved for type 2 diabetes) and Wegovy (approved for chronic weight management); the compounded version is a separate product prepared by a state-licensed compounding pharmacy operating under Section 503A.
How it works
Semaglutide acts on receptors in the brain and gut. It signals satiety, slows gastric emptying, and dampens food cravings. Most patients notice meaningful appetite suppression within the first 1 to 2 weeks. Doses are titrated upward over time to balance effectiveness with side-effect tolerance.
Who it's for
Adults with a BMI of 27 or higher, or 25 with weight-related conditions, who want a medically supervised path to sustained weight loss. Not for everyone — your provider screens for contraindications including personal or family history of medullary thyroid carcinoma, pancreatitis, or active gallbladder disease.
What patients value
- Weekly dosing with a gradual titration schedule set by your provider
- Prepared by a state-licensed 503A compounding pharmacy
- Flexible compounded dosing for tolerance and titration
- Strong safety profile in long-term clinical use
- Free shipping nationwide
Worth considering
- Mild nausea and reduced appetite are most common in the first weeks
- Compounded medications are not FDA-approved as finished products
- Insurance typically does not cover compounded GLP-1 medications
- Requires consistent self-injection (weekly)
Questions
Semaglutide, answered.
More questions answered in the full FAQ.
More on Semaglutide
Considering Semaglutide?
Share your health history online. A licensed provider will determine whether this protocol is appropriate for you.
Takes ~5 min · 100% online · No insurance needed
Compounded medications are not FDA-approved. All prescriptions require evaluation and approval by an independently licensed medical provider. Individual results vary.